Kronos Bio, Inc. Quarterly Depreciation, Depletion and Amortization in USD from Q3 2019 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
Summary
Kronos Bio, Inc. quarterly/annual Depreciation, Depletion and Amortization history and growth rate from Q3 2019 to Q2 2023.
  • Kronos Bio, Inc. Depreciation, Depletion and Amortization for the quarter ending June 30, 2023 was $600K, unchanged year-over-year.
  • Kronos Bio, Inc. Depreciation, Depletion and Amortization for the twelve months ending June 30, 2023 was $2.28M, a 4.02% increase year-over-year.
  • Kronos Bio, Inc. annual Depreciation, Depletion and Amortization for 2022 was $2.27M, a 14.6% increase from 2021.
  • Kronos Bio, Inc. annual Depreciation, Depletion and Amortization for 2021 was $1.98M, a 136% increase from 2020.
  • Kronos Bio, Inc. annual Depreciation, Depletion and Amortization for 2020 was $839K, a 136% increase from 2019.
Depreciation, Depletion and Amortization, Trailing 12 Months (USD)
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 $2.28M $600K $0 0% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $2.28M $569K +$12K +2.15% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $2.27M $509K -$24K -4.5% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-15
Q3 2022 $2.29M $600K +$100K +20% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $2.19M $600K +$100K +20% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $2.09M $557K +$113K +25.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $1.98M $533K -$267K -33.4% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-15
Q3 2021 $2.24M $500K +$300K +150% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $1.94M $500K +$400K +400% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $1.54M $444K +$284K +178% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $1.26M $800K +$400K +100% Oct 1, 2020 Dec 31, 2020 10-K 2021-03-23
Q3 2020 $860K $200K +$100K +100% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $760K $100K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $160K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q4 2019 $400K Oct 1, 2019 Dec 31, 2019 10-K 2021-03-23
Q3 2019 $100K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.